Al18F-NOTA-LM3 PET/CT in Patients With Pheochromocytoma and Paraganglioma
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorPeking Union Medical College Hospital
About this trial
The aim of this study is to evaluate the diagnostic performance of Al18F-NOTA-LM3 PET/CT and compare it with 68Ga-DOTATATE PET/CT in patients with pheochromocytoma/paraganglioma (PPGL).
Eligibility criteria
Qualifiers
Patients aged 18 to 80 years.
Suspected or confirmed PPGL patients.
Disqualifiers
Combined with other types of tumors.
Severe liver or renal dysfunction (ALT/AST≥5 ULN, GFR<30ml/min).
Pregnant or breast-feeding women.
Inability to perform PET/CT scans.
Trial design
Treatments tested in this trial
- Diagnostic Test: Al18F-NOTA-LM3
- Diagnostic Test: 68Ga-DOTATATE
Treatment groups
40 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov